DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pentavalent antimonial
Pentavalent antimonial
Review Article Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
T. Cruzi Invasion Summary Leishmania Phagosome
Review
Topical Treatment of Cutaneous Leishmaniasis
Identification and Characterization of Novel Anti-Leishmanial Compounds
Manual for the Diagnosis and Treatment of Leishmaniasis
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Redalyc.Influence of Gentamicine on the Pharmacokinetic of A
N-Metil Glucamine and Topical Miltefosine Association In
204684Orig1s000
Pancreatic Toxicity As an Adverse Effect Induced by Meglumine Antimoniate Therapy in a Clinical Trial for Cutaneous Leishmaniasis
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: a Systematic Review
Versão Do Arquivo Anexado / Version of Attached File: Versão Do Editor / Published Version Mais Informações No Site Da Edito
Molecular Targets and Pathways for the Treatment of Visceral Leishmaniasis
Antimonial Drugs Entrapped Into Phosphatidylserine Liposomes: Physicochemical Evaluation and Antileishmanial Activity
In Vivo Experiments Demonstrate the Potent Antileishmanial Efficacy of Repurposed Suramin in Visceral Leishmaniasis
Sodium Stibogluconate: Therapeutic Use in the Management of Leishmaniasis
Chemotherapy of Leishmaniasis – a Review
Top View
Treatment of Leishmaniasis in HIV-Positive Patients
Current Treatment of Leishmaniasis: a Review Lianet Monzote*
Revista6vol86v6 ING Layout 1
Leishmanicidal Therapy Targeted to Parasite Proteases
Sodium Stibogluconate and Il-2 for Treating Cancer Stibogluconate-Natrium Und Il-2 Zur Krebsbehandlung Stibogluconate De Sodium Et Il-2 Pour Le Traitement Du Cancer
A Review of Current Treatments Strategies Based on Paromomycin for Leishmaniasis A.P.S
Australian Statistics on Medicines 2009
Pdf 331.71 K
A Case of Cutaneous Leishmaniasis Responding to Systemic Liposomal Amphotericin B Treatment
Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: a Systematic Review
Pentavalent Antimonials: New Perspectives for Old Drugs
The Design and Synthesis of Cyanines and Arylimidamide Azole
The Pentavalent Antimonial Therapy Against Experimental Leishmania Amazonensis Infection Is More Effective Under the Inhibition of the NF- Κb Pathway
Successful Treatment with Intralesional Meglumine Antimoniate in Recurrent Cutaneous Leishmaniasis: Case Report
Uptake and Antileishmanial Activity of Meglumine Antimoniate-Containing
Guidelines for ATC Classification and DDD Assignment 2021
Guidelines on Use of Miltefosine
Trypanosomatid Aquaporins: Roles in Physiology and Drug Response
(12) Patent Application Publication (10) Pub. No.: US 2017/0211121 A1 Stern Et Al
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Guidelines for ATC Classification and DDD Assignment 2013
S613 Official Symposium Therapy of Parasitic Infections: a Large Task for Few Drugs E
The Selection and Use of Essential Medicines
Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: a Retrospective Study
Universidade Federal Do Amazonas Instituto De Ciências Biológicas Programa Multi-Institucional De Pós- Graduação Em Biotecnologia
Chemotherapy Stutfies Chapter IV Chemotherapy Studies
Noninferiority of Miltefosine Versus Meglumine Antimoniate For
ATC Code Title
The Need for New Antiparasitic Agents
Injectable Paromomycin for Visceral Leishmaniasis in India
CHAPTER E26 Pharmacology of Agents Used to Treat Parasitic Infections
Interventions for American Cutaneous and Mucocutaneous Leishmaniasis (Review)